BIOLASE

Sonendo Executes Asset Purchase Agreement to Acquire Biolase Assets

Sonendo, Inc. (OTCQX: SONX) (“Sonendo” or “company”), a leading dental technology company and developer...

BIOLASE Files for Chapter 11, Pursues Asset Sale to Sonendo

BIOLASE, Inc. (NASDAQ: BIOL) (the “company”), a global leader in dental lasers, recently announced...

BIOLASE Reports Unaudited Revenue Growth for Full Year 2023 and Provides Outlook for Full Year 2024

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue...

BIOLASE Enhances Education Offerings in 2024

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, has experienced growing demand...

BIOLASE Receives Second Top Workplaces 2023 Award

BIOLASE announced that the company has been honored with the Top Workplaces 2023 recognition...

BIOLASE Receives Top Workplaces 2023 Award

BIOLASE announced it has been awarded a Top Workplaces 2023 honor by Orange County...

BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial

BIOLASE has recently announced the successful completion of a trial program showcasing the Waterlase...

BIOLASE Announces Pricing of $1.4 Million Registered Direct Offering

BIOLASE announced that it has entered into a securities purchase agreement with a single...

Laser Offers Faster Healing, Less Patient Discomfort

Waterlase iPlus is BIOLASE’s flagship, most capable laser offering practice-changing, patient-preferred all-tissue laser dentistry....

BIOLASE to Report Second Quarter 2023 Results on 8/10/23

BIOLASE has announced that it will release its financial and operating results for the...